2007年底,英国国家病人安全局(NPSA)就2003年11月-2007年7月间所报告的、因使用口服抗癌药物而发生的3起致死以及400例安全性事件的报告表达了看法,并就此特向具有处方和使用权的专业人士提出了此类药物的使用原则。在上述期间报告的涉及口服抗癌药的安全性事件中,与罗氏公司的 The end of 2007, the British National Patient Safety Agency (NPSA) on November 2003 -2007 in July reported that due to the use of oral anticancer drugs occurred in the three fatal and 400 cases of safety incidents reported the views expressed, In this regard, special prescriptions and access to professionals have put forward the principle of the use of such drugs. In the above period reported in the safety incident involving oral anticancer drugs, with Roche’s